Study of prostate cancer patients in Algeria
Describes prostate cancer patients' characteristics, diagnosis, and treatment in Algeria.
Plain-language title generated from the registry record
Registry title: Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
Key facts
- Where
- Adrar, Algiers, Annaba, Blida, Constantine, Mostaganem, Oran, Sétif, Tipasa, and Tizi Ouzou, AlgeriaSee the 24 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men aged 19 and older with prostate cancer confirmed by tissue or lab tests. They must be followed in the taking-part cancer departments in Algeria.
- Age
- 19 years and older
- Sex
- Men only
- Disease stage
- Prostate cancer confirmed by tissue examination and/or lab tests. The record names no stage.
Main reasons for not taking part
- Tumour types other than carcinoma
- Secondary tumours
- Taking part in an interventional study
Read by machine on 9 November 2026.
Where in Algeria
- CAC Adrar - Oncology DepartmentAdrar, AlgeriaNot yet recruiting
- CAC Adrar - Radiotherapy DepartmentAdrar, AlgeriaNot yet recruiting
- CAC BLIDA - Oncology DepartmentAlgiers, AlgeriaTaking people
- Centre Pierre et Marie Curie - Oncology DepartmentAlgiers, AlgeriaTaking people
- Centre Pierre et Marie Curie - Radiology DepartmentAlgiers, AlgeriaTaking people
- CHU Bab El OuedAlgiers, AlgeriaTaking people
- CHU Béni Messous - Oncology DepartementAlgiers, AlgeriaTaking people
- EPH ROUIBA - Oncology DepartmentAlgiers, AlgeriaTaking people
- CAC Annaba - Oncology DepartementAnnaba, AlgeriaTaking people
- CAC Annaba - Radiotherapy DepartmentAnnaba, AlgeriaTaking people
- CAC Annaba - Urology DepartementAnnaba, AlgeriaTaking people
- CAC Bida - Radiotherapy DepartmentBlida, AlgeriaTaking people
- CAC BLIDA - Urology DepartmentBlida, AlgeriaTaking people
- CHU Constantine - Oncology DepartementConstantine, AlgeriaTaking people
- EH Constantine - Oncology DepartementConstantine, AlgeriaTaking people
- EPH Mostaghanem - Oncology DepartmentMostaganem, AlgeriaTaking people
- CAC ORAN - Oncology DepartmentOran, AlgeriaTaking people
- CAC ORAN - Radiotherapy DepartmentOran, AlgeriaTaking people
- EHU ORAN - Oncology DepartmentOran, AlgeriaNot yet recruiting
- EHU ORAN - Urology DepartmentOran, AlgeriaTaking people
- CAC Sétif - Oncology DepartementSétif, AlgeriaTaking people
- CAC Sétif - Radiotherapy DepartmentSétif, AlgeriaTaking people
- EPH Sidi Ghilès - Oncology DepartmentTipasa, AlgeriaTaking people
- CAC Draa Ben Khedda - Radiotherapy DepartementTizi Ouzou, AlgeriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Société Algérienne de Formation et Recherche en Oncologie
- Trial code
- NCT07484971
- Record updated
- 17 April 2026
- Original description
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer.Read full original descriptionShow less
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer.
It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Inclusion: Patients aged 19 years and older; Diagnosis of prostate cancer confirmed histologically and/or biologically; Patients followed in the participating oncology departments; Written informed consent obtained; Non Inclusion Criteria:; Histological types other than carcinoma; Secondary tumors; Participation in an interventional study.